IL1B and rheumatoid arthritis: These results support our initial hypothesis that a double inhibition of IL-1β and TNF could be effective in the treatment of inflammatory diseases, such as RA, and further indicate that the antiproliferative properties of gambogic acid may prove essential for an effective clinical control and to induce early remission in RA patients.